General Information of the Compound
Compound ID
CP0044706
Compound Name
(2E)-N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide
    Show/Hide
Synonyms
Dacinostat
(2E)-N-hydroxy-3-(4-{[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl}phenyl)prop-2-enamide
(2E)-N-hydroxy-3-[4-({(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide
(E)-N-Hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]meth yl]phenyl]prop-2-enamide
(E)-N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide
404951-53-7
CHEMBL356066
Dacinostat
Dacinostat [INN]
LAQ-824
LAQ824
LAQ824 (Dacinostat)
LBH539
NVP-LAQ 824
NVP-LAQ824
NVP-LAQ824, Dacinostat, LAQ824
UNII-V10P524501
V10P524501
    Show/Hide
Structure
Formula
C22H25N3O3
Molecular Weight
379.46
Canonical SMILES
OCCN(CCc1c[nH]c2ccccc12)Cc1ccc(\C=C\C(=O)NO)cc1
    Show/Hide
InChI
InChI=1S/C22H25N3O3/c26-14-13-25(12-11-19-15-23-21-4-2-1-3-20(19)21)16-18-7-5-17(6-8-18)9-10-22(27)24-28/h1-10,15,23,26,28H,11-14,16H2,(H,24,27)/b10-9+
    Show/Hide
InChIKey
BWDQBBCUWLSASG-MDZDMXLPSA-N
CAS
404951-53-7
Physicochemical Property
logP
2.7235
Rotatable Bonds
9
Heavy Atom Count
28
Polar Areas
88.59
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
4
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6445533
SID: 14877864
ChEMBL ID
CHEMBL356066
DrugBank ID
DB17034
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00991, Histone deacetylase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 2.6 nM
   TI
   LI
   LO
   TS
2
IC50 = 9 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 3.23 nM
2 IC50 = 8 nM
3 IC50 = 15 nM
4 Ki = 0.55 nM
5 Ki = 0.6 nM
Protein ID: PT00995, Histone deacetylase 3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 3.6 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.4 nM
2 IC50 = 9 nM
3 IC50 = 10.5 nM
4 Ki = 4.2 nM
Protein ID: PT01213, Histone deacetylase 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 8.3 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 5.93 nM
2 Ki = 9.5 nM
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 12200 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 10300 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000067 HCT 116 Homo sapiens (Human)  1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( NVP-LAQ824 )
Drug Name NVP-LAQ824
Company Corcept Therapeutics
Indication
Mood disorder
Phase 3
leukaemia
Discontinued in Phase 1/2
Multiple myeloma
Investigative
Target(s)
Histone deacetylase 1 (HDAC1)
Inhibitor